Blog
RSS FeedPosted by Michael Wonder on 24 Oct 2018
Seqirus receives FDA approval of Afluria Quadrivalent (influenza vaccine) for people six months of age and older in the U.S.
17 October 2018 - Seqirus today announced the U.S. FDA has approved Afluria Quadrivalent (influenza vaccine) for use in people ...
Posted by Michael Wonder on 21 May 2018
Flu vaccine supply shortfall triggered by unprecedented demand
21 May 2018 - An unprecedented increase in the number of people wanting flu vaccinations has caused a shortage in ...
Posted by Michael Wonder on 30 Apr 2018
Update of EU recommendations for 2018/2019 seasonal flu vaccine composition
30 April 2018 - Update to recommendations issued in March 2018. ...
Posted by Michael Wonder on 26 Apr 2018
PHARMAC turns down DHB request for free flu vaccine for 'super spreader' kids
24 April 2018 - Health authorities are bracing for a potentially deadly flu season in New Zealand this winter after ...
Posted by Michael Wonder on 18 Apr 2018
2018 influenza vaccines now available
18 April 2018 - More than 4.5 million Australians who are most at risk of getting sick during this year’s flu ...
Posted by Michael Wonder on 27 Mar 2018
2018 seasonal influenza vaccines
27 March 2018 - This year, four quadrivalent and two trivalent influenza vaccines will be available. ...
Posted by Michael Wonder on 26 Mar 2018
EU recommendations for 2018/2019 seasonal flu vaccine composition
26 March 2018 - EU advice based on WHO recommendations. ...
Posted by Michael Wonder on 26 Feb 2018
Statement from FDA Commissioner on FDA’s ongoing efforts to help improve effectiveness of influenza vaccines
26 February 2018 - The current influenza season has been especially difficult, causing widespread illness that has affected all fifty ...
Posted by Michael Wonder on 12 Feb 2018
Influenza vaccine for 2018 season
12 February 2018 - PHARMAC is pleased to announce a quadrivalent influenza vaccine will be supplied for the 2018 influenza ...
Posted by Michael Wonder on 30 Aug 2016
Seqirus receives FDA approval for Afluria Quadrivalent (influenza vaccine) for people 18 years of age and older
29 August 2016 - Seqirus is shipping trivalent and quadrivalent formulations of Afluria in the 2016-2017 influenza season. ...
Posted by Michael Wonder on 05 Aug 2016
Agreement for supply of influenza vaccine approved by PHARMAC
5 August 2016 - PHARMAC is pleased to announce the approval of an agreement with BGP Products Pty Ltd (trading as ...
Posted by Michael Wonder on 28 Jul 2016
TGA approves Afluria Quad
28 July 2016 - The TGA has approved CSL's Afluria Quad (quadrivalent influenza vaccine). ...
Posted by Michael Wonder on 24 May 2016
FDA approves CSL's Flucelvax quadrivalent influenza vaccine
24 May 2016 - CSL today announced that the US FDA has approved Seqirus’ Flucelvax Quadrivalent (Influenza Vaccine), the first four-strain, ...
Posted by Michael Wonder on 08 Apr 2016
TGA advice on 2016 seasonal influenza vaccines
8 April 2016 - The Australian Influenza Vaccine Committee (AIVC) has reviewed and evaluated data relating to the strains of influenza ...